|
|
Gene Symbol |
IL10 |
|
Aliases |
CSIF, GVHDS, IL-10, IL10A, TGIF |
|
Entrez Gene ID |
|
|
Gene Name |
Interleukin 10 |
|
Chromosomal Location |
1q32.1 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis.[provided by RefSeq, May 2011]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
SNPs
SNP Id |
Upstream Sequence |
SNP |
Downstream Sequence |
Functional Significance |
References |
|
|
C819T |
|
|
27617227 | |
|
|
G1082A |
|
|
27617227 | |
|
Protein Information |
|
Protein Name |
Interleukin-10, T-cell growth inhibitory factor, cytokine synthesis inhibitory factor |
|
Function |
Major immune regulatory cytokine that acts on many cells of the immune system where it has profound anti-inflammatory functions, limiting excessive tissue disruption caused by inflammation. Mechanistically, IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3 (PubMed:16982608). In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators (PubMed:18025162). Targets antigen-presenting cells (APCs) such as macrophages and monocytes and inhibits their release of pro-inflammatory cytokines including granulocyte-macrophage colony-stimulating factor /GM-CSF, granulocyte colony-stimulating factor/G-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8 and TNF-alpha (PubMed:1940799, PubMed:7512027, PubMed:11564774). Interferes also with antigen presentation by reducing the expression of MHC-class II and co-stimulatory molecules, thereby inhibiting their ability to induce T cell activation (PubMed:8144879). In addition, controls the inflammatory response of macrophages by reprogramming essential metabolic pathways including mTOR signaling (By similarity). |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00726 |
IL10 |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000303315 |
P17275 |
P17275 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Myocardial Infarction |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Wilson Disease |
|
Digestive System Diseases |
Crohn Disease |
|
Colitis |
24314293, 19238344, 22119709, 21807089, 26974007, 20228798, 19915572, 20228799, 18836448, 27580383, 21102463 |
Inflammatory Bowel Diseases |
|
Appendicitis |
|
Enteritis |
|
Irritable Bowel Syndrome |
|
Cholangitis |
|
Enterocolitis |
|
Ear Or Mastoid Diseases |
Meniere Disease |
|
Endocrine System Diseases |
Brittle diabetes |
|
Diabetes Mellitus |
|
Ketosis-prone diabetes |
|
PCOS |
|
Immune System Diseases |
Lupus Erythematosus |
|
Behcet Syndrome |
|
Libman-Sacks Disease |
|
HIV Infections |
|
Rheumatoid Arthritis |
|
HIV Coinfection |
|
Dermatitis |
|
Autoimmune Hepatitis |
|
Autoimmune Diabetes |
|
Musculoskeletal Diseases |
Spondylitis |
|
Neoplasms |
Lung Cancer |
|
Prostate cancer |
|
Multiple Sclerosis |
|
Leukemia |
|
Psychiatric/Brain disorders |
Schizophrenia |
|
Mental Depression |
|
Autistic Disorder |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Kidney Failure |
|
Kidney Insufficiency |
|
Nephritis |
|
Glomerulonephritis |
|
Reproductive disorders |
Chronic Prostatitis with Chronic Pelvic Pain Syndrome |
|
prostatitis |
|
Asymptomatic Inflammatory Prostatitis |
|
Bacterial Prostatitis |
|
Preeclampsia |
|
Respiratory Tract Diseases |
Pleuritis |
|
Skin and Connective Tissue Diseases |
Leishmaniasis |
|
Eczema |
|
Dermatitis |
|
Psoriasis |
|
|
References |
|
|
Talaat Roba M, Mohamed Yasmin A, Mohamad Ehab H, Elsharkawy Marwa, Guirgis Adel A |
Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt.| Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt.| Obstetrics and Gynecology Department, Faculty of Medicine, Al-Azhar University, Egypt.| Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Egypt.| Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt. |
Meta Gene. 2016 Aug 3;9:254-8. doi: 10.1016/j.mgene.2016.08.001. eCollection 2016 |
Abstract
Cytokines play critical roles in the pathogenesis of Polycystic Ovarian Syndrome (PCOS). This work was designed to study the implication of IL10 gene polymorphisms (- 1082 G/A and - 819 C/T) on the susceptibility of Egyptian women to have PCOS. Rotterdam consensus criteria were used to diagnose PCOS patients. Genotyping was performed by single-stranded polymorphism-polymerase chain reaction (SSP-PCR) in 61 PCOS patients and 80 healthy controls, and IL-10 serum levels were measured using Enzyme linked immunosorbent assay (ELISA). The frequency of IL10 - 1082 G/G (46%) genotype was significantly increased (p < 0.001) while the frequency of - 1082 A/A (16%) genotype was significantly decreased (p < 0.05) in PCOS patients compared to controls (14% and 35% for G/G and A/A genotypes; respectively). G allele (65%) is significantly increased (p < 0.01( in PCOS patients while A allele (61%) is significantly increased (p < 0.001( in control subjects. The distribution of IL10 -819 T/T genotype was significantly increased (p < 0.05) in PCOS group. G/G genotype (odd ratio (OR = 5.322) with confidence interval (CI = 2.364-11.982) and the G allele (OR = 2.828 with CI = 1.73-4.61) of - 1082 G/A and T/T genotype of - 819 C/T (OR = 4.18 with CI = 1.26-13.86) could be considered as risk factors for PCOS. IL-10 levels were significantly lower among PCOS patients (313.42 +/- 30.10) compared to normal controls (4914.36 +/- 303.72). Depending on our preliminary work, IL10 - 1082 G/G might be considered as a host genetic factor for PCOS susceptibility in Egyptian women. Studies concerning other cytokine gene polymorphisms are required to get a better understanding of the pathogenesis of PCOS disease. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|